trending Market Intelligence /marketintelligence/en/news-insights/trending/c0YCr9fnJN4Bk3VslQzG9w2 content esgSubNav
In This List

Kitov Pharma names deputy CEO/CFO

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Kitov Pharma names deputy CEO/CFO

Kitov Pharma Ltd. said it appointed Gil Efron as the company's deputy CEO and CFO.

Efron would replace Simcha Rock, who would step down as the company's CFO and continue to serve on the board.

Most recently, Efron served as deputy CEO and CFO of Kamada Ltd., a plasma-derived protein therapeutics company. He was also the CFO of RRsat Global Communications Ltd.

Israel-based Kitov Pharma develops treatments for pain caused by osteoarthritis and hypertension.